Stryker Corp
SYKNYSECIK 310764HealthcareFiscal year ends Dec 31
Reports and events: 318 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3011:08 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000310764-26-000061 |
| 2026-10-2916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000059 |
| 2026-10-0608:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-414956 |
| 2026-07-3111:41 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000310764-26-000050 |
| 2026-07-3016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000048 |
| 2026-06-2615:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000310764-26-000041 |
| 2026-05-2016:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-232643 |
| 2026-05-1111:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000310764-26-000031 |
| 2026-05-0813:02 ET | 8-K | 5.07 Shareholder vote results | 0000310764-26-000029 |
| 2026-04-3016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000025 |
| 2026-04-1412:59 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001242914-26-000005 |
| 2026-04-0916:05 ET | 8-K/A | 1.05 Material cybersecurity incident; 7.01 Regulation FD disclosure | 0001193125-26-149607 |
| 2026-03-2313:05 ET | DEF 14A | Proxy statementPeriod 2026-05-06 | 0000310764-26-000013 |
| 2026-03-2308:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-118634 |
| 2026-03-1217:09 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-104431 |
| 2026-03-1117:24 ET | 8-K | 8.01 Other events | 0001193125-26-102460 |
| 2026-02-1111:43 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000310764-26-000010 |
| 2026-01-2916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-26-000006 |
| 2025-12-0416:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-308097 |
| 2025-10-3110:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000310764-25-000129 |
| 2025-10-3016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000126 |
| 2025-08-0112:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000310764-25-000107 |
| 2025-07-3116:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000103 |
| 2025-05-1317:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000310764-25-000085 |
| 2025-05-0211:35 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000310764-25-000075 |
| 2025-05-0116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000072 |
| 2025-03-2513:16 ET | DEF 14A | Proxy statementPeriod 2025-05-08 | 0000310764-25-000051 |
| 2025-02-2716:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-039302 |
| 2025-02-1908:52 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0001193125-25-029187 |
| 2025-02-1211:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000310764-25-000023 |
| 2025-02-1016:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-023593 |
| 2025-02-1016:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-023587 |
| 2025-01-2816:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-014415 |
| 2025-01-2816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-25-000005 |
| 2025-01-0706:58 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-002537 |
| 2024-10-3012:35 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000310764-24-000115 |
| 2024-10-2916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000113 |
| 2024-09-1116:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-217275 |
| 2024-07-3110:51 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000310764-24-000098 |
| 2024-07-3016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000095 |
| 2024-05-1416:43 ET | 8-K | 5.07 Shareholder vote results | 0000310764-24-000081 |
| 2024-05-0111:52 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000310764-24-000064 |
| 2024-04-3016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000062 |
| 2024-03-2614:41 ET | DEF 14A | Proxy statementPeriod 2024-05-09 | 0000310764-24-000054 |
| 2024-02-1410:55 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000310764-24-000024 |
| 2024-01-3016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-24-000005 |
| 2023-12-1116:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-23-292590 |
| 2023-12-0816:54 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-291773 |
| 2023-11-0311:23 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000310764-23-000116 |
| 2023-11-0216:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000310764-23-000114 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 12:17 ET. Listed shows no prices and gives no investment advice.